Thermo Fisher Scientific Inc., and Project HOPE announced a new partnership to improve the wellbeing and treatment outcomes of adolescents and young persons living with HIV in Nigeria, the country with the second larger HIV epidemic worldwide. Nigeria currently accounts for nearly two million individuals living with HIV, contributing to approximately two-thirds of new HIV infections in West and Central Africa. The partnership greatly advances Project HOPE?s efforts in Northwestern Nigeria by expanding access to critical community HIV testing services.

Project HOPE, supported by local community partners, will identify and help connect more HIV positive adolescents and young persons with appropriate treatment and essential social and economic support services, ultimately improving their wellbeing and quality of life. Additionally, Thermo Fisher will engage its employees in volunteer opportunities to augment the services delivered by Project HOPE. Thermo Fisher?s previous support for Project HOPE?s initiatives in countries like Ukraine laid the foundation for the new collaboration to address infectious diseases, particularly HIV/AIDS.

This partnership builds on Thermo Fisher?s collaborations with customers, governments and nonprofit organizations to create a more equitable global healthcare environment. For instance, in 2022, the company launched an HIV drug resistance genotyping kit with global heath equity pricing, an offering that?s been adopted by over 30 low- and middle-income countries across Africa, Latin America, the Middle East and Asia; and which has helped drive health policy changes in Kenya. For over a decade, Project HOPE has been collaborating with public, private, and government partners to improve health in Nigeria.

With a focus on HIV/AIDS, Project HOPE strives to support government, local partners, and communities to prevent new infections and enhance health outcomes for the most vulnerable populations in line with the UNAIDS targets toward achieving epidemic control.